Petrus Bekker, SVP of Medical & Clinical at ChemoCentryx, Inc. (CCXI), sold 3,979 shares at $14.03 ($56K) on 2013-04-11, disclosed to the SEC on 2013-04-12.
Scheduled sale ($56k) by SVP of Medical & Clinical under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| CCXI | SELL | 2017-06-30 | $760K | — | Filing → |
| CCXI | SELL | 2016-12-20 | $134K | — | Filing → |
| CCXI | SELL | 2016-12-07 | $255K | — | Filing → |